Serial #98640064
LIVE

Serial Number

98640064

Owner

Bora Health Inc.

Attorney

Hui Zhang

Filing Date

Jul 9, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98640064 Trademark

Serial Number: 98640064

Serial #98640064 is a trademark filed by Bora Health Inc. on July 9, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Bora Health Inc. (2 trademarks)

Ruiguang Rd., Neihu Dist.
Taipei City 114009 , TW

Entity Type: 03

Trademark Details

Filing Date

July 9, 2024

Registration Date

Not Registered

Published for Opposition

February 25, 2025

Goods & Services

Vitamin preparations; Medicinal herbs; Herbal teas for medicinal purposes; Food for babies; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Mineral dietary supplements; Nutritional supplements ; Dietary supplements with a cosmetic effect; Dietary supplements for human beings; Antiallergic medicines; Sulphonamides as medicines; Medicines for intestinal disorders; Medicines for dental purposes; Medicines for alleviating constipation; Motion sickness medicines; Medicines for the treatment of gastrointestinal diseases; Prescription and nonprescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Ocular pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Anti-diabetic pharmaceuticals; Pharmaceuticals, namely, psychotropics; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceuticals, namely, lipid lowering agents; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Astringents for medical purposes; Pharmaceutical preparations for wounds; Dermatological pharmaceutical products; Pharmaceutical skin lotions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for skin care; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations for use in urology; Pharmaceutical products and preparations for chloasma; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating diabetes; Pharmaceutical solutions used in dialysis; Pharmaceutical products for ophthalmological use; Antiepileptic pharmaceutical preparations; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating hypertension; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating halitosis; Effervescent analgesic pharmaceutical preparations; Pharmaceutical products for the prevention and treatment of cancer; Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products for the treatment of joint disease; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the relief of insect bites; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders

Filing History

CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 26, 2026 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU TEAS EXTENSION RECEIVED
Sep 8, 2025 EEXT
SOU EXTENSION 1 GRANTED
Sep 8, 2025 EX1G
SOU EXTENSION 1 FILED
Sep 8, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 8, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 22, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 4, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 4, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 4, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 4, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 4, 2025 CNEA
ASSIGNED TO EXAMINER
Jan 31, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2025 NWOS
NEW APPLICATION ENTERED
Jul 9, 2024 NWAP